Insider Trading Activity Gilead Sciences, Inc. (NASDAQ:GILD) – EVP Sold 40,000 shares of Stock

ME Staff
-
0

Insider Trading Activity For Gilead Sciences, Inc. (NASDAQ:GILD)

Gregg H Alton , EVP of Gilead Sciences, Inc. (NASDAQ:GILD) reportedly Sold 40,000 shares of the company’s stock at an average price of 74 for a total transaction amount of $2,960,000.00 SEC Form

Insider Trading History For Gilead Sciences, Inc. (NASDAQ:GILD)

  • On 9/4/2012 Gregg H Alton, EVP, sold 44,000 with an average share price of $57.50 per share and the total transaction amounting to $2,530,000.00.View SEC Filing
  • On 10/2/2012 Robin L Washington, CFO, sold 29,500 with an average share price of $68.62 per share and the total transaction amounting to $2,024,290.00.View SEC Filing
  • On 10/3/2012 John F Milligan, COO, sold 140,000 with an average share price of $69.85 per share and the total transaction amounting to $9,779,000.00.View SEC Filing
  • On 11/12/2012 Robin L Washington, CFO, sold 55,950 with an average share price of $73.11 per share and the total transaction amounting to $4,090,504.50.View SEC Filing
  • On 12/3/2012 John C Martin, CEO, sold 291,000 with an average share price of $75.01 per share and the total transaction amounting to $21,827,910.00.View SEC Filing
  • On 12/3/2012 Gregg H Alton, EVP, sold 44,000 with an average share price of $75.10 per share and the total transaction amounting to $3,304,400.00.View SEC Filing
  • On 2/28/2013 Olsen Per Wold, Director, bought 10,000 with an average share price of $43.05 per share and the total transaction amounting to $430,500.00.View SEC Filing

    • Analyst Ratings For Gilead Sciences, Inc. (NASDAQ:GILD)
    These are 11 Hold Ratings, 14 Buy Ratings, 1 Strong Buy Rating .
    The current consensus rating for Gilead Sciences, Inc. (NASDAQ:GILD) is Buy (Score: 2.62) with a consensus target price of $80.32 , a potential (8.93% upside)

    Analyst Ratings History For Gilead Sciences, Inc. (NASDAQ:GILD)

    • On 9/10/2015 Jyske Bank Upgraded rating Strong-Buy with a price target of $125.00
    • On 12/18/2015 Atlantic Securities Initiated Coverage of rating Neutral with a price target of $111.00
    • On 2/3/2016 Standpoint Research Initiated Coverage of rating Buy with a price target of $110.00
    • On 5/4/2016 Oppenheimer Holdings, Inc. Reiterated Rating Buy with a price target of $120.00 to $116.00
    • On 7/27/2016 S&P Equity Research Reiterated Rating Strong-Buy
    • On 7/29/2016 Argus Downgraded rating Buy to Hold with a price target of $88.00 to $81.00
    • On 10/15/2016 Evercore ISI Set Price Target of rating Buy with a price target of $90.00

    Dividend Information For Gilead Sciences, Inc. (NASDAQ:GILD)
    Gilead Sciences, Inc. (NASDAQ:GILD) pays an annual dividend of Community Ranking: with a yield of Community Ranking:

    Dividend History For Gilead Sciences, Inc. (NASDAQ:GILD)

  • On 4/30/2015 Gilead Sciences, Inc. announced a quarterly dividend of $0.43 with an ex dividend date of 6/12/2015 which will be payable on 6/29/2015.
  • On 7/28/2015 Gilead Sciences, Inc. announced a quarterly dividend of $0.43 1.49% with an ex dividend date of 9/14/2015 which will be payable on 9/29/2015.
  • On 10/27/2015 Gilead Sciences, Inc. announced a quarterly dividend of $0.43 1.59% with an ex dividend date of 12/14/2015 which will be payable on 12/30/2015.
  • On 2/2/2016 Gilead Sciences, Inc. announced a quarterly dividend of $0.43 1.99% with an ex dividend date of 3/14/2016 which will be payable on 3/30/2016.
  • On 4/28/2016 Gilead Sciences, Inc. announced a quarterly dividend of $0.47 2.13% with an ex dividend date of 6/14/2016 which will be payable on 6/29/2016.
  • On 7/25/2016 Gilead Sciences, Inc. announced a quarterly dividend of $0.47 2.32% with an ex dividend date of 9/14/2016 which will be payable on 9/29/2016.
  • On 11/1/2016 Gilead Sciences, Inc. announced a quarterly dividend of $0.47 2.59% with an ex dividend date of 12/13/2016 which will be payable on 12/29/2016.

    • Recent Trading Activity for Gilead Sciences, Inc. (NASDAQ:GILD)
    Shares of Gilead Sciences, Inc. closed the previous trading session at 73.74 down -0.65 -0.87% with 8,910,934 shares trading hands.